Our Blog

Mesoblast (ASX:MSB) wins Biotech award for Remestemcel-L

15 Sep 2020 – Mesoblast (ASX:MSB), today announced that its lead product candidate remestemcel-L has been selected as the winner of the Fierce Innovation Awards – Life Sciences Edition 2020 for Biotech Innovation.


Source: Finance News Network

Share this post